Enhancement of tumor killing using a combination of tumor immunization and HSV-tk suicide gene therapy

International Journal of Cancer

Volumn 80, Issue 3, 1999, Pages 380-386

  Ramesh, Rajagopal ^a,c   Munshi, Anupama ^a,c   Marrogi, Aizen J ^a   Freeman, Scott M ^b,d  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GANCICLOVIR; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; MESSENGER RNA; THYMIDINE KINASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER IMMUNIZATION; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FIBROSARCOMA; GENE THERAPY; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; MACROPHAGE; MOUSE; NONHUMAN; OVARY ADENOCARCINOMA; PRIORITY JOURNAL; SUICIDE GENE; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL DESTRUCTION; TUMOR CELL LINE;

ANIMALS; ANTIVIRAL AGENTS; COMBINED MODALITY THERAPY; FEMALE; GANCICLOVIR; GENE THERAPY; HUMANS; IMMUNIZATION; IMMUNOTHERAPY; INTERLEUKIN-1; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; NEOPLASM PROTEINS; RNA, MESSENGER; SPECIFIC PATHOGEN-FREE ORGANISMS; T-LYMPHOCYTES; THYMIDINE KINASE; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; VIRAL PROTEINS;

EID: 0032961941     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990129)80:3<380::AID-IJC8>3.0.CO;2-G     Document Type: Article

References (22)

1. BI, W.L., PARYSEK, L.M., WARNICK, R. and STAMBROOK, P.J., In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV-tk retroviral gene therapy. Hum. Gene Ther., 4, 725-731 (1993).
2. CARSWELL, E.A., OLD, L.J., KASSEL, R.L., GREEN, S., FIORE, N. and WILLIAMSON, B., An endotoxin induced serum factor that causes necrosis of tumors. Proc. nat. Acad. Sci. (Wash.), 12, 366-367 (1975).
3. CARUSO, M., PANIS, Y., GAGANDEEP, S., HOUSSIN, D., SALZMANN, J.L. and KLATZMANN, D., Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc. nat. Acad. Sci. (Wash.), 90, 7024-7028 (1993).
4. CAVENDER, D.E., HASKARD, D.O., JOSEPH, B. and ZIFF, M., Interleukin 1 increases the binding of human B and T lymphocytes to endothelial cell monolayers. J. Immunol., 136, 203-207 (1986).
5. FERMIN, C.D., GERBER, M.A. and TORRE-BUENO, J., Color thresholding and objective quantification in bio-imaging. J. Microscopy, 167, 85-96 (1992).
6. FREEMAN, S.M., ABBOUD, C.N., WHARTENBY, K.A. and ABRAHAM, G.N., The bystander effect: tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res., 53, 5274-5283 (1993).
7. FREEMAN, S.M., MCCUNE, C.S., ABBOUD, C.N. and ABRAHAM, G.N., Treatment of ovarian cancer using HSV-tk gene-modified cells. Hum. Gene Ther., 3, 342-349 (1992).
8. FREEMAN, S.M., RAMESH, R. and MARROGI, A.J., Immune system in suicide gene therapy. Lancet, 3, 2-3 (1997).
9. FREEMAN, S.M., RAMESH, R., SHASTRI, M., MUNSHI, A., JENSEN, A. and MARROGI, A.J., The role of cytokines in mediating the bystander effect using HSV-tk xenogeneic cells. Cancer Lett., 92, 167-174 (1995).
10. GAGANDEEP, S., BREW, R., GREEN, B., CHRISTMAS, S.E., KLATZMANN, D., POSTON, G.J. and KINSELLA, A.R., Prodrug activated gene therapy. Involvement of an immunological component in the bystander effect. Cancer Gene Ther., 3, 83-88 (1996).
11. HARADA, T., KAN, N., OKINO, T., ICHNIOSE, Y., MORIGUCHI, Y., LI, L., SUGIE, T., OHGAKI, K. and IMAMURA, M., The induction of specific antitumor immunity by in vivo treatment with interleukin-1 and sonicated tumor extract in a murine model. Surg. Today, 24, 561-563 (1994).
12. MESNIL, M., PICCOLI, C., TIRABY, G., WILLECKE, K. and YAMASAKI, H., Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins. Proc. nat. Acad. Sci. (Wash.), 93, 1831 (1996).
13. MOOLTEN, F.L., Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res., 46, 5276-5281 (1986).
14. NAKANO, K., OKUGAWA, K., FURUICHI, H., MATSUI, Y. and SOHMURA, Y., Augmentation of the generation of cytotoxic T lymphocytes against syngeneic tumor cells by recombinant tumor necrosis factor. Cell Immunol., 120, 154-164 (1989).
15. PALLADINO, M.A., JR. and 12 OTHERS, Characterization of the anti-tumor activities of human tumor necrosis factor α and the comparison with other cytokines: induction of tumor-specific immunity. J. Immunol., 138, 4023-4032 (1987).
16. RAMESH, R., MARROGI, A.J., MUNSHI, A., ABBOUD, C.N. and FREEMAN, C.N., In-vivo analysis of the "bystander effect": a cytokine cascade. Exp. Hematol., 24, 829-838 (1996).
17. RAMESH, R., MUNSHI, A., MARROGI, A.J. and FREEMAN, S.M., Expression of co-stimulatory molecules: B7 and ICAM up-regulation following treatment with the suicide gene. Cancer Gene Ther., 3, 373-384 (1996).
18. SOUTHERN, E.M., Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol., 98, 503-517 (1975).
19. VILE, R.G., CASTLEDEN, S.C., MARSHALL, J., COMPLEJOHN, R., UPTON, C. and CHONG, H., Generation of a Th1-like immune response in a non-immunogenic tumor: HSV-tk killing in vivo stimulates a mononuclear cell infiltrate and a Th1-like profile of intratumoral cytokine expression. Int. J. Cancer, 71, 267-274 (1997a).
20. VILE, R.G., DIAZ, R.M., CASTLEDEN, S. and CHONG, H., Targeted gene therapy for cancer: herpes simplex virus thymidine kinase gene-mediated cell killing leads to anti-tumor immunity that can be augmented by co-expression of cytokines in the tumor cells. Biochem. Soc. Trans., 25, 717-725 (1997b).
21. VILE, R.G., NELSON, J.A., CASTLEDEN, S., CHONG, H. and HART, I.R., Systemic gene therapy of murine melanoma using tissue specific expression of the HSV-tk gene involves an immune component. Cancer Res., 54, 6228-6234 (1994).
22. WHARTENBY, K.A., MARROGI, A.J., ABBOUD, C.N., RAMESH, R. and FREEMAN, S.M., The biology of cancer gene therapy. Lab. Invest., 72, 131-145 (1995).